Please ensure Javascript is enabled for purposes of website accessibility

Why Hexo, Canopy Growth, and Aurora Cannabis Stocks Are Dropping Today

By Rich Smith - May 13, 2021 at 3:20PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's good news for marijuana legalization -- but bad news for cannabis stocks.

What happened

On a bright day for the stock market in general -- the S&P 500 is up a solid 1.5% -- marijuana stocks are wilting today. As of 2:35 p.m. EDT, three of the best-known names in the sector, Hexo (HEXO 1.67%), Canopy Growth (CGC 7.41%), and Aurora Cannabis (ACB -4.42%), are down 3.1%, 3.6%, and 5.3%, respectively.

So what

Scan the newsfeeds today, and there's no bad news to be found. No negative press releases from any of the companies themselves. No downgrades from stock market analysts -- not so much as a lowered price target.

Cartoon characters confused by stock chart arrow falling and crashing into floor

Image source: Getty Images.

Actually, the contrary is true. If there's any news of relevance to report today, it's that in the halls of Congress, two Republican lawmakers have just introduced a bill to legalize marijuana at the federal level, and to "protect banks that service state-legal cannabis business and ensure that military veterans are specifically permitted to use marijuana in compliance with state laws," reports MarijuanaMoment.net.

When viewed in conjunction with last month's news that Senate Majority Leader (and Democrat) Chuck Schumer has called "to end the federal prohibition on marijuana in this country," this certainly seems to suggest that there's now bipartisan support, and support in both bodies of Congress, for legalizing marijuana federally.

Now what

Why would this development translate into falling stock prices for cannabis stocks like Hexo, Canopy, and Aurora? It honestly makes no sense to me -- except for one thing.

Hope for a national marijuana legalization bill has been behind the surge in marijuana stock prices ever since then Democratic presidential and vice presidential candidates Joe Biden and Kamala Harris threw their support behind the idea in last year's campaign. It's the catalyst that investors have been hoping would lift their stocks higher. But if and when legalization happens, what then?

Then, the onus may fall upon Hexo, Canopy, and Aurora -- each of which sells cannabis legally in Canada today, but hasn't been able to make a profit off of it -- to explain why they can't make a profit off of legal marijuana in the United States, either.

In the end, the most important factor moving marijuana stocks may not be legalization -- but profits.

Rich Smith has no position in any of the stocks mentioned. The Motley Fool recommends HEXO Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$1.73 (-4.42%) $0.08
Canopy Growth Stock Quote
Canopy Growth
CGC
$4.06 (7.41%) $0.28
HEXO Stock Quote
HEXO
HEXO
$0.26 (1.67%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
402%
 
S&P 500 Returns
129%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.